ArticleFrontiers in immunology2022

Integrating transcriptomics and network analysis-based multiplexed drug repurposing to screen drug candidates for M2 macrophage-associated castration-resistant prostate cancer bone metastases.

Jinyuan Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.